Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > RDW speculation.
View:
Post by DJDawg on Dec 19, 2022 1:28pm

RDW speculation.

I've heard a few questions raised about RDW role. I'll start by saying I have no idea. However,  I have hopes.

Since he is not the CEO, the science guy or the CFO he has to have a certain amount of free time compared to company members with more complete roles. Business development role is pretty vague.

Most oncology IPO's that launch in the biotech space, before even human trials seem to have market caps in the rage of 100m and up. So without human data, these companies are valued quite highly based on the animal data and the ideas around how they will work and succeed. If TLT were a Boston biotech IPO, presenting the NSLC and GBM animal data to VC investors, I have no doubt that they woud be an easy 100m ipo and up.

Given, RDW has no real job, I'll really like to belive that he has been spending his time working on contacts and connections with larger companies whereby he shows them some of our data and gets a feel if they may be interested. Setting up the groundwork for who is a good jv partner or funding partner. I suspect that, as the founder of the company, his plan has been to keep it low and slow till he is back as CEO in mid Feb. Then he can be the CEO that announces BTD, JV funding, IND application for NSLC and GBM etc. I really can't see how they have stayed this small so long if they were actually trying to get JV relationships. It is almost a planned slow process to do the basics (slow and steady NMIBC trial) while waiting for mid Feb. It might even explain the wimpy PP that were just to raise a small amount to get through 6m. A bigger PP would have been destabilizing. If the price gets a bit of a jump from ANYTHING in terms of news, then the warrants should bring in cash to keep rolling.

Just my speculation on how RDW plays a role in the background.
Comment by Impalaman on Dec 19, 2022 2:15pm
DgDawg---You took the words right out of my mouth-----with you're post-----How can that be----there must be something to it--if you and I am thinking the same thing---Dam that is just amazing---Let's see if it comes true.----JV could be in the works---behind the scene.
Comment by Rumpl3StiltSkin on Dec 19, 2022 6:35pm
Guys, I think that speculation is totally reasonable...
Comment by ScienceFirst on Dec 19, 2022 3:31pm
DJDAWG... Good post. Without COVID-19, our pivotal Ph. 2 trial would have already been completed almost 2y ago.  So hard to plan timing for Feb. 2023 as enrollment was anyway out of the control of TLT. But the investment of the management under different vehicules in: - May (investing their own money), - Sept (participating in a small pp), - Oct. (participating in another pp that was ...more  
Comment by BudFoxx2020 on Dec 20, 2022 8:49am
The only speculation here is if Sciencefirst is RWD himself or which employee of TLT is sciencfirst. Once again I am just speculating as well.  Since you mentioned he must have a certain amount of free time.  I mean who sits on this board 24/7 posting everyday for the last 15 to 20 years.  This board is a great lesson for new investors to see how these small group of posters and ...more  
Comment by 99942Apophis on Dec 20, 2022 9:36am
You're probably just as correct as anyone here BudFoxx2020 all personal opinions. We do learn off each other and sure SF posts a bit more than others but you have to admit SF has come up with a lot of great information. 
Comment by ScienceFirst on Dec 20, 2022 10:32am
BudFoxx2020 is silencing the FDA application and the obligation for the FDA to respond.   You can see his agenda right there.  Unless it's his incompetency.  Or both! The guy is just playing FUD.  Providing no de, no perspectives, no nothing.  Only FUD.  We see this type of clown on every boards.  
Comment by BudFoxx2020 on Dec 20, 2022 10:41am
They have been submitting applications since the late 90s.  30 years later they are still submitting applications, hence the share price.  I believe they have submitted every application from A to Z possible.  Lol.  Alright that was my entertainment for today.  Good luck all.  I will check back in a month to see if anything has progressed or how nothing has progressed ...more  
Comment by gebremeskel on Dec 20, 2022 12:14pm
This post has been removed in accordance with Community Policy
Comment by plantrader on Dec 20, 2022 10:47am
SF, arguments & basher/pumper nonsense aside... what FDA application? We haven't been notified of anything yet, right? FDA can't respond until the company applies & the lack of updates isn't exactly comforting. Confirmation of submission would be great before EOY, but not looking good for that at this point due to the usual holiday vacations, etc. For personal expectation ...more  
Comment by DJDawg on Dec 20, 2022 10:53am
fyi - I have searched high and low and can find no example of company announcing application for BTD. Yes for BLA, NDA, IND. But not for BDT. It seems they announce if they got it and that is it.
Comment by plantrader on Dec 20, 2022 10:58am
DJDawg, thanks for that! I'm kind of glad to hear that, so I guess we'll hear a yes at some point immediately upon designation. Or a no, at some point possibly not so quick. I couldn't find any info about applications for BTD being announced, but I'm much less versed at finding that sort of info compared to many of you. Thanks again.
Comment by DJDawg on Dec 20, 2022 11:04am
If they don't get it, it will just disappear off the roadmap on the corp presentation. They are allowed to have a pre-meeting to talk to fda about whether the package looks good enough for BTD. The FDA person would likely say that they are good to go if x number of patients treated and x% are CR. If some future corp presentation update has the BTD disappear then you know that they were shot ...more  
Comment by ScienceFirst on Dec 20, 2022 11:04am
DJDawg ... good work.  In line with what I once documented.
Comment by ScienceFirst on Dec 20, 2022 10:59am
Plantrader ... It's already been discussed.  Announcing application for BTD is not material.  So at the discretion of the company.  But the final decision of the FDA is material though. I recently documented different examples, from TLT and abroad. The only thing that is sure is that TLT has reached the milestone requested by the FDA to apply;  450-days of p#25.  And ...more  
Comment by plantrader on Dec 20, 2022 11:05am
SF, thanks for that info. Now I don't have to wonder why they're silent. This board was such a mess for a while, it's tough to go back to refresh or find older info/posts.
Comment by Oilminerdeluxe on Dec 20, 2022 9:42am
Dude, EVERYONE expected a PP to come. It is nothing to be negative about since they build the compajy. If more comes, so be it, and who cares?? As long as the end game is our product coming to market
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250